| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
110.17 |
22.03 |
132.2 |
4% |
4.41 |
114.58 |
22.92 |
137.5 |
16% |
17.63 |
132.21 |
26.44 |
158.65 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
22.65 |
4.53 |
27.18 |
6% |
1.36 |
24.01 |
4.8 |
28.81 |
18% |
4.08 |
28.09 |
5.62 |
33.71 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2321 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.18 |
8.84 |
53.02 |
4% |
1.77 |
45.95 |
9.19 |
55.14 |
16% |
7.07 |
53.02 |
10.6 |
63.62 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-4567/03.09.2014( в сила от 18.09.2014) |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.2 |
2.24 |
13.44 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-2808/17.02.2014 |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.2 |
8.84 |
53.04 |
4% |
1.77 |
45.97 |
9.19 |
55.16 |
16% |
7.07 |
53.04 |
10.61 |
63.65 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
13.28 |
2.66 |
15.94 |
6% |
0.8 |
14.08 |
2.82 |
16.9 |
18% |
2.39 |
16.47 |
3.29 |
19.76 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
106.77 |
21.35 |
128.12 |
4% |
4.27 |
111.04 |
22.21 |
133.25 |
16% |
17.08 |
128.12 |
25.62 |
153.74 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
16.31 |
3.26 |
19.57 |
6% |
0.98 |
17.29 |
3.46 |
20.75 |
18% |
2.94 |
20.23 |
4.05 |
24.28 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2319 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
938.76 |
187.75 |
1126.51 |
4% |
10 |
948.76 |
189.75 |
1138.51 |
16% |
25 |
973.76 |
194.75 |
1168.51 |
корекц. Решение НСР-3464/16.05.2014 |
НСР-3307/24.04.2014 |
08.05.2014 |
08.05.2014 |
Активен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, mg, Pack: 2 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
945.33 |
189.07 |
1134.4 |
4% |
10 |
955.33 |
191.07 |
1146.4 |
16% |
25 |
980.33 |
196.07 |
1176.4 |
|
НСР-1037/23.08.2013 |
09.09.2013 |
09.09.2013 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
469.4 |
93.88 |
563.28 |
4% |
10 |
479.4 |
95.88 |
575.28 |
16% |
25 |
504.4 |
100.88 |
605.28 |
Цената се заличава с решение НСР-3636/29.05.2014 ( в сила от 13.06.2014) |
НСР-79/07.06.2013 |
02.07.2013 |
02.07.2013 |
Заличен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
685.3 |
137.06 |
822.36 |
4% |
10 |
695.3 |
139.06 |
834.36 |
16% |
25 |
720.3 |
144.06 |
864.36 |
|
КЦРР-869/26.06.2012 |
24.07.2012 |
24.07.2012 |
Неактивен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
697.08 |
139.42 |
836.49 |
6% |
15 |
712.08 |
142.42 |
854.49 |
18% |
30 |
742.08 |
148.42 |
890.49 |
|
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Неактивен |
1880 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, -, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter AG - Austria |
639.91 |
127.98 |
767.89 |
4% |
10 |
649.91 |
129.98 |
779.89 |
16% |
25 |
674.91 |
134.98 |
809.89 |
|
КЦРР-217/27.02.2012 |
13.03.2012 |
13.03.2012 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, -, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter AG - Austria |
694.32 |
138.86 |
833.18 |
6% |
15 |
709.32 |
141.86 |
851.18 |
18% |
30 |
739.32 |
147.86 |
887.18 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.4 |
126.48 |
758.88 |
4% |
10 |
642.4 |
128.48 |
770.88 |
16% |
25 |
667.4 |
133.48 |
800.88 |
|
НСР-2195/20.12.2013 |
06.02.2014 |
06.02.2014 |
Активен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.4 |
126.48 |
758.88 |
4% |
10 |
642.4 |
128.48 |
770.88 |
16% |
25 |
667.4 |
133.48 |
800.88 |
|
НСР-2195/20.12.2013 |
06.02.2014 |
06.02.2014 |
Неактивен |
2439 |
| Felodipine |
0057/20,06,2007 |
Felicipin, Prolonged release tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK |
5.55 |
1.11 |
6.66 |
7% |
0.39 |
5.94 |
1.19 |
7.13 |
20% |
1.11 |
7.05 |
1.41 |
8.46 |
промяна на обстоятелства КЦPP-579/04.05.2012 |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Активен |
208 |
| Felodipine |
4055/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany |
8.61 |
1.72 |
10.33 |
7% |
0.6 |
9.21 |
1.84 |
11.05 |
20% |
1.72 |
10.93 |
2.19 |
13.12 |
цената се заличава КЦРР-2931/20.03.2013 |
КЦРР-1847/12.12.2012 г |
08.02.2013 |
08.02.2013 |
Заличен |
1572 |
| Felodipine |
4054/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany |
4.13 |
0.83 |
4.96 |
7% |
0.29 |
4.42 |
0.88 |
5.3 |
20% |
0.83 |
5.25 |
1.05 |
6.3 |
цената се заличава КЦРР-2935/20.03.2013 |
КЦРР-1847/12.12.2012 г |
08.02.2013 |
08.02.2013 |
Заличен |
1571 |
| Felodipine |
4055/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Ratiopharm BV - Холадия; Merckle GmbH - Germany |
9 |
1.8 |
10.8 |
7% |
0.63 |
9.63 |
1.93 |
11.56 |
20% |
1.8 |
11.43 |
2.29 |
13.72 |
|
КЦ-803/07.04.2009 |
23.04.2009 |
23.04.2009 |
Неактивен |
1572 |
| Felodipine |
4054/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Ratiopharm BV - Холадия; Merckle GmbH - Germany |
4.69 |
0.94 |
5.63 |
7% |
0.33 |
5.02 |
1 |
6.02 |
20% |
0.94 |
5.96 |
1.19 |
7.15 |
|
КЦ-803/07.04.2009 |
23.04.2009 |
23.04.2009 |
Неактивен |
1571 |
| Felodipine |
ІІ-4866/14.05.2009 г. |
FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайка фарма-висококачествените лекарства" АД, гр. Пловдив, България |
4.63 |
0.93 |
5.56 |
7% |
0.32 |
4.95 |
0.99 |
5.94 |
20% |
0.93 |
5.88 |
1.18 |
7.06 |
|
КЦ-959/15.06.2009 |
01.07.2009 |
01.07.2009 |
Активен |
764 |
| Felodipine |
ІІ-9504/05.08.2004 г. |
FeloHEXAL, Prolonged release tablet, 5, mg, Pack: 30 |
Hexal AG, Германия |
Salutas Pharma GmbH, Germany |
4.5 |
0.9 |
5.4 |
7% |
0.32 |
4.82 |
0.96 |
5.78 |
20% |
0.9 |
5.72 |
1.14 |
6.86 |
|
НСР-7486/12.11.2015 |
27.11.2015 |
27.11.2015 |
Активен |
1361 |
| Felodipine |
ІІ-9435/02.08.2004 г. |
FeloHEXAL, Prolonged release tablet, 10, mg, Pack: 30 |
Hexal AG, Германия |
Salutas Pharma GmbH, Germany |
2.97 |
0.59 |
3.56 |
7% |
0.21 |
3.18 |
0.64 |
3.82 |
20% |
0.59 |
3.77 |
0.75 |
4.52 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-201/30.04.2015 |
НСР-1817/25.11.2013 |
02.06.2015 |
02.06.2015 |
Активен |
3884 |